Search

Louise Warnich

CYP2B6*6 and CYP2B6*18 predict long-term efavirenz exposure measured in hair samples in HIV-positive South African women
Evaluation of predictive CYP2C19 genotyping assays relative to measured phenotype in a South African cohort
Considerations for rare variants in drug metabolism genes and the clinical implications
Patterns of variation influencing antipsychotic treatment outcomes in South African first-episode schizophrenia patients
Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study
Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment
Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohort
Chromosome 22q11 in a Xhosa schizophrenia population
End of the beginning and public health pharmacogenomics: knowledge in âMode 2âand P5 medicine
Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation
Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications
Characterization of the genetic profile of CYP2C19 in two South African populations
Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population

Published with Wowchemy — the free, open source website builder that empowers creators.